miR-31 has a known role in prostate cancer and melanoma, suppressing key cell cycle regulators and pro-oncogenic genes such as CDK1, E2F2, EXO1, FOXM1, MCM2, Src or MET [11]. The gene discussed is E2F2; the disease is prostate cancer.